Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Self-Limited Cytomegalovirus Infection During Natalizumab Treatment for Multiple Sclerosis
View through CrossRef
Natalizumab is indicated as monotherapy for the treatment of relapsing-remitting multiple sclerosis; it prevents outbreaks and delays the progression of physical disability. Here, we report the case of a 30-year-old patient with multiple sclerosis receiving natalizumab as monotherapy who subsequently developed self-limited cytomegalovirus disease. Cytomegalovirus infection has been reported during treatment with natalizumab, and in this study, we use new techniques to analyze the possible association of cytomegalovirus infection with natalizumab.
Title: Self-Limited Cytomegalovirus Infection During Natalizumab Treatment for Multiple Sclerosis
Description:
Natalizumab is indicated as monotherapy for the treatment of relapsing-remitting multiple sclerosis; it prevents outbreaks and delays the progression of physical disability.
Here, we report the case of a 30-year-old patient with multiple sclerosis receiving natalizumab as monotherapy who subsequently developed self-limited cytomegalovirus disease.
Cytomegalovirus infection has been reported during treatment with natalizumab, and in this study, we use new techniques to analyze the possible association of cytomegalovirus infection with natalizumab.
Related Results
Treatment with natalizumab and ocrelizumab in multiple sclerosis
Treatment with natalizumab and ocrelizumab in multiple sclerosis
In this thesis, our research regarding personalized treatment with natalizumab and ocrelizumab in multiple sclerosis (MS) by extending treatment intervals and the road towards impl...
CYTOMEGALOVIRUS INFECTION IN PREGNANT WOMEN WITH HIV INFECTION
CYTOMEGALOVIRUS INFECTION IN PREGNANT WOMEN WITH HIV INFECTION
Purpose: еstablishment of the frequency of infection and clinical forms of cytomegalovirus infection in pregnant women with HIV infection. Materials and methods. A retrospective an...
THUR 171 Natalizumab effectiveness and safety in top uk patients
THUR 171 Natalizumab effectiveness and safety in top uk patients
IntroductionThe TYSABRI® Observational Program (TOP) is an ongoing, global open-label study enrolling natalizumab-treated relapsing-remitting multiple sclerosis patients in real-wo...
Maternal and fetal cytomegalovirus infection: diagnosis, management, and prevention
Maternal and fetal cytomegalovirus infection: diagnosis, management, and prevention
Congenital cytomegalovirus infection is a major cause of central nervous system and sensory impairments that affect cognition, motor function, hearing, language development, vestib...
Hearing Loss in Children With Congenital Cytomegalovirus Infection in Relation to the Maternal Trimester in Which the Maternal Primary Infection Occurred
Hearing Loss in Children With Congenital Cytomegalovirus Infection in Relation to the Maternal Trimester in Which the Maternal Primary Infection Occurred
OBJECTIVES. The purpose of this work was to study the relation between maternal trimester of primary infection with cytomegalovirus and the occurrence of sensorineural hearing loss...
Leflunomide therapy for refractory cytomegalovirus infections in hematopoietic stem cell transplant recipients
Leflunomide therapy for refractory cytomegalovirus infections in hematopoietic stem cell transplant recipients
Background Currently, there are no prospective, randomized trials analyzing leflunomide for the treatment of cytomegalovirus infection or disease in allogeneic stem cell transplant...
Narrative review based on fingolimod therapy in pediatric MS
Narrative review based on fingolimod therapy in pediatric MS
The course of pediatric-onset multiple sclerosis and adult multiple sclerosis shows some clinical differences. The rate of having a second attack after the first clinical event is ...
The Impact of IL28B Gene Polymorphisms on Drug Responses
The Impact of IL28B Gene Polymorphisms on Drug Responses
To achieve high therapeutic efficacy in the patient, information on pharmacokinetics, pharmacodynamics, and pharmacogenetics is required. With the development of science and techno...